A Dose Finding Trial for Angiotensin II in Hypertensive Adults on Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Anesthesia-Mediated Hypotension
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2019
Price : $35 *
At a glance
- Drugs Angiotensin II (Primary)
- Indications Hypotension
- Focus Therapeutic Use
- 09 Oct 2019 Planned End Date changed from 1 Jan 2020 to 1 Oct 2020.
- 09 Oct 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Oct 2020.
- 15 Aug 2019 Status changed from not yet recruiting to recruiting.